JoVE Logo
Faculty Resource Center

Sign In

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

DOI :

10.3791/54850-v

December 10th, 2016

December 10th, 2016

11,954 Views

1Department of Population Health and Pathobiology, North Carolina State University College of Veterinary Medicine, 2Department of Pathology and Laboratory Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine

This protocol outlines the cefoperazone mouse model of Clostridium difficile infection (CDI) using a clinically-relevant and genetically-tractable strain, R20291. Emphasis on clinical disease monitoring, C. difficile bacterial enumeration, toxin cytotoxicity, and histopathological changes throughout CDI in a mouse model are detailed in the protocol.

Tags

Cefoperazone treated

-- Views

Related Videos

article

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

article

Prevention of Heat Stress Adverse Effects in Rats by Bacillus subtilis Strain

article

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

article

Influenza A Virus Studies in a Mouse Model of Infection

article

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

article

A Purification and In Vitro Activity Assay for a (p)ppGpp Synthetase from Clostridium difficile

article

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

article

Measurement of Pulse Propagation Velocity, Distensibility and Strain in an Abdominal Aortic Aneurysm Mouse Model

article

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

article

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved